Abstract
Background: Although patients with chronic obstructive pulmonary disease (COPD) receive poor-quality palliative care, information about the use of palliative sedation (PS) in the last days of life is very scarce. Objectives: To compare the use of PS in hospitalized patients who died from COPD or lung cancer and identify factors correlating with PS application. Methods: In a retrospective observational cohort study, from 1,675 patients died at a teaching hospital between 2013 and 2015, 109 patients who died from COPD and 85 from lung cancer were compared. Sociodemographic data, clinical characteristics, health care resource utilization, application of PS and prescribed drugs were recorded. Results: In the last 6 months of life, patients who died from COPD had more hospital admissions due to respiratory causes and less frequent support by a palliative home care team (PHCT). Meanwhile, during their last hospitalization, patients who died from COPD had fewer do-not-resuscitate orders and were subjected to more intensive care unit admissions and cardiopulmonary resuscitation maneuvers. PS was applied less frequently in patients who died from COPD than in those who died from lung cancer (31 vs. 53%, p = 0.002). Overall, previous use of opioid drugs, support by a PHCT, and a diagnosis of COPD (adjusted odds ratio 0.48, 95% CI: 0.26–0.89, p = 0.020) were retained as factors independently related to PS. In COPD patients, only previous use of opioid drugs was identified as a PS-related factor. Conclusion: During their last days of life, hospitalized COPD patients receive PS less frequently than patients with lung cancer.
Literatur
1.
Lopez
AD
, Mathers
CD
, Ezzati
M
, Jamison
DT
, Murray
CJ
. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data
. Lancet
. 2006
;367
(9524
):1747
–57
. .2.
Lozano
R
, Naghavi
M
, Foreman
K
, Lim
S
, Shibuya
K
, Aboyans
V
, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
. Lancet
. 2012
;380
(9859
):2095
–128
. .3.
Faes
K
, De Frène
V
, Cohen
J
, Annemans
L
. Resource use and health care costs of COPD patients at the end of life: a systematic review
. J Pain Symptom Manage
. 2016
;52
(4
):588
–99
. .4.
Smith
MC
, Wrobel
JP
. Epidemiology and clinical impact of major comorbidities in patients with COPD
. Int J Chron Obstruct Pulmon Dis
. 2014
;9
:871
–88
. .5.
Vogelmeier
CF
, Criner
GJ
, Martinez
FJ
, Anzueto
A
, Barnes
PJ
, Bourbeau
J
, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary
. Am J Respir Crit Care Med
. 2017
;195
(5
):557
–82
. .6.
Elkington
H
, White
P
, Addington-Hall
J
, Higgs
R
, Pettinari
C
. The last year of life of COPD: a qualitative study of symptoms and services
. Respir Med
. 2004
;98
(5
):439
–45
. .7.
Maddocks
M
, Lovell
N
, Booth
S
, Man
WD
, Higginson
IJ
. Palliative care and management of troublesome symptoms for people with chronic obstructive pulmonary disease
. Lancet
. 2017
;390
(10098
):988
–1002
. .8.
Gershon
AS
, Maclagan
LC
, Luo
J
, To
T
, Kendzerska
T
, Stanbrook
MB
, et al. End-of-life strategies among patients with advanced chronic obstructive pulmonary disease
. Am J Respir Crit Care Med
. 2018
;198
(11
):1389
–96
. .9.
Claessens
MT
, Lynn
J
, Zhong
Z
, Desbiens
NA
, Phillips
RS
, Wu
AW
, et al. Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to understand prognoses and preferences for outcomes and risks of treatments
. J Am Geriatr Soc
. 2000
;48
(5 Suppl
):S146
–53
. .10.
Gore
JM
, Brophy
CJ
, Greenstone
MA
. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer
. Thorax
. 2000
;55
(12
):1000
–6
. .11.
Au
DH
, Udris
EM
, Fihn
SD
, McDonell
MB
, Curtis
JR
. Differences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancer
. Arch Intern Med
. 2006
;166
(3
):326
–31
. .12.
Cohen
J
, Beernaert
K
, Van den Block
L
, Morin
L
, Hunt
K
, Miccinesi
G
, et al. Differences in place of death between lung cancer and COPD patients: a 14-country study using death certificate data
. NPJ Prim Care Respir Med
. 2017
;27
(1
):14
. .13.
van der Plas
AG
, Oosterveld-Vlug
MG
, Pasman
HR
, Onwuteaka-Philipsen
BD
. Relating cause of death with place of care and healthcare costs in the last year of life for patients who died from cancer, chronic obstructive pulmonary disease, heart failure and dementia: a descriptive study using registry data
. Palliat Med
. 2017
;31
(4
):338
–45
. .14.
De Schreye
R
, Smets
T
, Deliens
L
, Annemans
L
, Gielen
B
, Cohen
J
. Appropriateness of end-of-life care in people dying from COPD. Applying quality indicators on linked administrative databases
. J Pain Symptom Manage
. 2018
;56
(4
):541
–50
. .15.
Kreuter
M
, Herth
FJ
. Supportive and palliative care of advanced nonmalignant lung disease
. Respiration
. 2011
;82
(4
):307
–16
. .16.
De Graeff
A
, Dean
M
. Palliative sedation therapy in the last weeks of life: a literature review and recommendations for standards
. J Palliat Med
. 2007
;10
(1
):67
–85
. .17.
Janssens
JP
, Weber
C
, Herrmann
FR
, Cantero
C
, Pessina
A
, Matis
C
, et al. Can early introduction of palliative care limit intensive care, emergency and hospital admissions in patients with severe chronic obstructive pulmonary disease? A pilot randomized study
. Respiration
. 2019
;97
(5
):406
–15
. .18.
Donker
GA
, Slotman
FG
, Spreeuwenberg
P
, Francke
AL
. Palliative sedation in Dutch general practice from 2005 to 2011: a dynamic cohort study of trends and reasons
. Br J Gen Pract
. 2013
;63
(615
):e669
–75
. .19.
Kirk
TW
, Mahon
MM
. National hospice and palliative care organization (NHPCO) position statement and commentary on the use of palliative sedation in imminently dying terminally ill patients
. J Pain Symptom Manage
. 2010
;39
(5
):914
–23
. .20.
Cherny
NI
, Radbruch
L
. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care
. Palliat Med
. 2009
;23
(7
):581
–93
. .21.
Sykes
N
, Thorns
A
. Sedative use in the last week of life and the implications for end-of-life decision making
. Arch Intern Med
. 2003
;163
(3
):341
–4
. .22.
Claessens
P
, Menten
J
, Schotsmans
P
, Broeckaert
B
. Palliative sedation: a review of the research literature
. J Pain Symptom Manage
. 2008
;36
(3
):310
–33
. .23.
Rietjens
JA
, van Zuylen
L
, van Veluw
H
, van der Wijk
L
, van der Heide
A
, van der Rijt
CC
. Palliative sedation in a specialized unit for acute palliative care in a cancer hospital: comparing patients dying with and without palliative sedation
. J Pain Symptom Manage
. 2008
;36
(3
):228
–34
. .24.
Maltoni
M
, Pittureri
C
, Scarpi
E
, Piccinini
L
, Martini
F
, Turci
P
, et al. Palliative sedation therapy does not hasten death: results from a prospective multicenter study
. Ann Oncol
. 2009
;20
(7
):1163
–9
. .25.
Curtis
JR
. Palliative and end-of-life care for patients with severe COPD
. Eur Respir J
. 2008
;32
(3
):796
–803
. .26.
Skilbeck
J
, Mott
L
, Page
H
, Smith
D
, Hjelmeland-Ahmedzai
S
, Clark
D
. Palliative care in chronic obstructive airways disease: a needs assessment
. Palliat Med
. 1998
;12
(4
):245
–54
. .27.
Hyasat
K
, Sriram
KB
. Evaluation of the patterns of care provided to patients with COPD compared to patients with lung cancer who died in hospital
. Am J Hosp Palliat Care
. 2016
;33
(8
):717
–22
. .28.
Kuo
LC
, Chen
JH
, Lee
CH
, Tsai
CW
, Lin
CC
. End-of-life health care utilization between chronic obstructive pulmonary disease and lung cancer patients
. J Pain Symptom Manage
. 2019
;57
(5
):933
–43
. .29.
Fahim
A
, Kastelik
JA
. Palliative care understanding and end-of-life decisions in chronic obstructive pulmonary disease
. Clin Respir J
. 2014
;8
(3
):312
–20
. .30.
Gardiner
C
, Gott
M
, Payne
S
, Small
N
, Barnes
S
, Halpin
D
, et al. Exploring the care needs of patients with advanced COPD: an overview of the literature
. Respir Med
. 2010
;104
(2
):159
–65
. .31.
Faes
K
, Cohen
J
, Annemans
L
. Resource use during the last six months of life among COPD patients: a population-level study
. J Pain Symptom Manage
. 2018
;56
(3
):318
–26
. .32.
Lau
KS
, Tse
DM
, Tsan Chen
TW
, Lam
PT
, Lam
WM
, Chan
KS
. Comparing noncancer and cancer deaths in Hong Kong: a retrospective review
. J Pain Symptom Manage
. 2010
;40
(5
):704
–14
. .33.
Bloom
CI
, Slaich
B
, Morales
DR
, Smeeth
L
, Stone
P
, Quint
JK
. Low uptake of palliative care for COPD patients within primary care in the UK
. Eur Respir J
. 2018
;51
(2
):1701879
. .34.
Goodridge
D
, Lawson
J
, Duggleby
W
, Marciniuk
D
, Rennie
D
, Stang
M
. Health care utilization of patients with chronic obstructive pulmonary disease and lung cancer in the last 12 months of life
. Respir Med
. 2008
;102
(6
):885
–91
. .35.
Ahmadi
Z
, Lundström
S
, Janson
C
, Strang
P
, Emtner
M
, Currow
DC
, et al. End-of-life care in oxygen-dependent COPD and cancer: a national population-based study
. Eur Respir J
. 2015
;46
(4
):1190
–3
. .36.
The SUPPORT Principal Investigators
. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT principal investigators
. JAMA
. 1995
;274
(20
):1591
–8
..37.
Teno
JM
, Gozalo
PL
, Bynum
JPW
, Leland
NE
, Miller
SC
, Morden
NE
, et al. Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009
. JAMA
. 2013
;309
(5
):470
–7
. .38.
Prado
BL
, Gomes
DBD
, Usón Júnior
PLS
, Taranto
P
, França
MS
, Eiger
D
, et al. Continuous palliative sedation for patients with advanced cancer at a tertiary care cancer center
. BMC Palliat Care
. 2018
;17
(1
):13
. .39.
Mercadante
S
, Porzio
G
, Valle
A
, Fusco
F
, Aielli
F
, Costanzo
V
. Palliative sedation in patients with advanced cancer followed at home: a systematic review
. J Pain Symptom Manage
. 2011
;41
(4
):754
–60
. .40.
Scheerens
C
, Beernaert
K
, Pype
P
, Cohen
J
, Deliens
L
, Chambaere
K
. Comparing the use and timing of palliative care services in COPD and lung cancer: a population-based survey
. Eur Respir J
. 2018
;51
(5
):1702405
. 41.
Godbout
K
, Tremblay
L
, Lacasse
Y
. A distress protocol for respiratory emergencies in terminally ill patients with lung cancer or chronic obstructive pulmonary disease
. Am J Hosp Palliat Care
. 2016
;33
(9
):817
–22
. .42.
Dean
MM
. End-of-life care for COPD patients
. Prim Care Respir J
. 2008
;17
(1
):46
–50
. .43.
Gainza-Miranda
D
, Sanz-Peces
EM
, Alonso-Babarro
A
, Varela-Cerdeira
M
, Prados-Sánchez
C
, Vega-Aleman
G
, et al. Breaking barriers: prospective study of a cohort of advanced chronic obstructive pulmonary disease patients to describe their survival and end-of-life palliative care requirements
. J Palliat Med
. 2019
;22
(3
):290
–6
. .© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
